Drug Profile
Recombinant batroxobin - BioBud
Alternative Names: BB Rb1; BB-rB1; Rec-BLatest Information Update: 28 Dec 2017
Price :
$50
*
At a glance
- Originator BioBud
- Class
- Mechanism of Action Fibrinogen inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Blood coagulation disorders
Most Recent Events
- 28 Dec 2017 No recent reports of development identified for phase-I development in Coagulation-disorders(Prevention, In volunteers) in South Korea (IV, Injection)